Changes

Jump to navigation Jump to search

Regeneron (view source)

Revision as of 02:47, November 10, 2020

841 bytes added ,  02:47, November 10, 2020
a start
'''Regeneron''' is the experimental medication given to President [[Donald Trump]] for treating [[COVID-19]]. Regeneron is a coronavirus antibody cocktail

On October 30, 2020, the company Regeneron announced that an independent data monitoring committee overseeing the clinical trials recommended that the company cease enrolling hospitalized patients who require a ventilator (or high-flow oxygen) and that this recommendation was due to a potential safety issue as well as an unfavorable risk/benefit profile in the trial data.

Earlier Regeneron applied to the [[FDA]] for an emergency use authorization for this antibody cocktail.

Regeneron's antibody cocktail is manufactured from antibodies found in the blood of those contracted [[coronavirus]] but recovered.

Lilly also has an antibody treatment for [[COVID-19]].
{{coronavirus}}
Aschlafly
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,616

edits

Retrieved from "https://www.conservapedia.com/Special:MobileDiff/1703301"

Navigation menu